Day: November 23, 2020

SALT LAKE CITY, Nov. 23, 2020 (GLOBE NEWSWIRE) — CONVERGENCE® AV Network Manager software from ClearOne (NASDAQ:CLRO) now supports its new Ceiling Tile Beamforming Microphone Array, the BMA 360.  In addition, CONVERGENCE has been upgraded to increase its database connection pool to an effectively unlimited number of ClearOne devices and users on a single network.  CONVERGENCE software is a unified AV network management platform to monitor, control, and audit ClearOne Pro Audio and Video products and services. Remote real-time system access provides at-a-glance and all-inclusive dashboard views with unlimited scalability designed to support organizations of any size. The powerful and elegant user interface works on any browser from desktop to mobile, keeping administrators up-to-date with email status notifications and the ability...

TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) — TELUS has been awarded the HPE-IAPP Privacy Innovation Award by the International Association of Privacy Professionals in recognition of its Data for Good program. Launched in April 2020 in response to the COVID-19 pandemic, Data for Good leverages an advanced approach to de-identified data analytics to aid all levels of government and public agencies in making more strategic and informed decisions based on real-world information.“We are extremely proud of the contribution TELUS has made to Canadians’ understanding of COVID-19 and our ability to measure many elements of the response to the pandemic,” said Pam Snively, Chief Data & Trust Officer at TELUS. “We believe that there is a very clear and strategic benefit to our society that can be achieved by using de-identified data to aid...

Banco Comercial Português, S.A. informs about notice of acquisition of securitiesAttachment2020 11 23 Aquisição de títulos EN

Raison sociale de l’émetteur : Société Générale S.A. – SA au capital de 1 066 714 367,50 euros                                                                     Immatriculée sous le n° 552 120 222 R.C.S. PARIS                                                                     Siège social : 29, Boulevard Haussmann, 75009 ParisPièce jointeSociete-Generale-Actions-et-droits-de-vote-au-31-octobre-2020

Name of issuer:                          Société Générale S.A. – French public limited company (“SA”) with a share capital of 1,066,714,367.50 euros                                                               Registered under nr.552 120 222 R.C.S. PARIS                                                               Registered office: 29, Boulevard Haussmann, 75009 Paris AttachmentSociete-Generale-shares-and-voting-rights-as-of-31-octobre-2020

TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM) (“Wallbridge” or the “Company”) today announced that it has entered into an option agreement (the “Option Agreement”) with respect to its Detour East gold property (“Detour East” or the “Property”) with Kirkland Lake Gold Inc. (“Kirkland”), a wholly owned subsidiary of Kirkland Lake Gold Ltd. (TSX:KL). Under terms of the Option Agreement, Kirkland can earn a 75% interest in Detour East by making expenditures totalling $35 million on the Property, as described below and in the Company’s news release of September 14, 2020.Under the terms of the Option Agreement, Wallbridge will grant Kirkland the option to acquire up to an undivided 50% interest in the Property by funding phase 1 expenditures of $7.5 million over five (5) years (the “Phase 1 Expenditures”)...

Clazosentan demonstrates significant reduction of vasospasm-related morbidity and all-cause mortality in patients following aneurysmal subarachnoid hemorrhage (aSAH)Clazosentan demonstrates significant reduction of all-cause morbidity and mortality in patients following aSAH in a pre-planned pooled analysis of data from both studies.Idorsia Japan to file New Drug Application (NDA) with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) in the first half of 2021Global Phase 3 study “REACT” investigating the efficacy and safety of clazosentan for the prevention of clinical deterioration due to vasospasm-related delayed cerebral ischemia in adult patients following aSAH continues to actively recruitAllschwil, Switzerland – November 23, 2020Idorsia Ltd (SIX: IDIA) today announced positive top-line results of the Japanese registration...

Clazosentan demonstrates significant reduction of vasospasm-related morbidity and all-cause mortality in patients following aneurysmal subarachnoid hemorrhage (aSAH)Clazosentan demonstrates significant reduction of all-cause morbidity and mortality in patients following aSAH in a pre-planned pooled analysis of data from both studies.Idorsia Japan to file New Drug Application (NDA) with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) in the first half of 2021Global Phase 3 study “REACT” investigating the efficacy and safety of clazosentan for the prevention of clinical deterioration due to vasospasm-related delayed cerebral ischemia in adult patients following aSAH continues to actively recruitAllschwil, Switzerland – November 23, 2020Idorsia Ltd (SIX: IDIA) today announced positive top-line results of the Japanese registration...